Suppr超能文献

基于互联网的种系基因检测在转移性前列腺癌男性中的应用。

Internet-Based Germline Genetic Testing for Men With Metastatic Prostate Cancer.

机构信息

University of Washington, Seattle, WA.

Fred Hutchinson Cancer Center, Seattle, WA.

出版信息

JCO Precis Oncol. 2023 Jan;7:e2200104. doi: 10.1200/PO.22.00104.

Abstract

PURPOSE

Germline mutations in DNA repair genes are present in approximately 10% of men with metastatic prostate cancer (mPC), and guidelines recommend genetic germline testing. Notable barriers exist, including access to genetic counseling, insurance coverage, and out-of-pocket costs. The GENTleMEN study was designed to determine the feasibility of an Internet-based, patient-driven germline genetic testing approach for men with mPC.

PATIENTS AND METHODS

In this prospective cohort study, men with mPC provided informed consent via an Internet-based platform and completed a questionnaire including demographics and family cancer history. Supporting medical data were also collected. Genetic testing was performed using the Color Genomics 30-gene targeted panel of cancer predisposition genes on a mailed saliva sample. Men whose test results identified a germline pathogenic or likely pathogenic variant received results by phone or telehealth genetic counseling; other participants received results by email with an option for phone-based or telehealth genetic counseling.

RESULTS

As of August 18, 2021, 816 eligible men were consented, of whom 68% (551) completed genetic testing, and 8.7% (48 of 551) were found to carry a pathogenic or likely pathogenic variant in a germline DNA repair gene: (17), (15), (6), (3), (2), (2), (2), and (1). Participants were more likely to complete the testing process if they were non-Hispanic White, married, highly educated, or from a higher-income bracket.

CONCLUSION

Here, we show the feasibility of delivering germline (inherited) genetic testing by a voluntary, patient-driven, Internet-based platform to men with mPC. Preliminary results show rates of germline DNA repair mutations, consistent with other cohorts. Although feasible for some, reduced steps for participation, more dedicated diverse outreach and participant support, and identification and addressing of additional barriers is needed to ensure equitable access and optimization.

摘要

目的

在转移性前列腺癌(mPC)男性中,约有 10%存在 DNA 修复基因的种系突变,指南建议进行种系遗传检测。目前存在显著障碍,包括获得遗传咨询、保险覆盖和自付费用。GENTLEMEN 研究旨在确定一种基于互联网、由患者驱动的种系基因检测方法在 mPC 男性中的可行性。

患者和方法

在这项前瞻性队列研究中,mPC 男性通过基于互联网的平台提供知情同意,并完成包括人口统计学和家族癌症史的问卷。还收集了支持性医疗数据。遗传检测是使用邮寄唾液样本的 Color Genomics 30 基因靶向癌症易感性基因面板进行的。检测结果确定存在种系致病性或可能致病性变异的男性通过电话或远程健康遗传咨询获得结果;其他参与者通过电子邮件获得结果,并可选择通过电话或远程健康遗传咨询。

结果

截至 2021 年 8 月 18 日,符合条件的 816 名男性同意参与,其中 68%(551 名)完成了基因检测,8.7%(551 名中的 48 名)在种系 DNA 修复基因中发现致病性或可能致病性变异: (17)、 (15)、 (6)、 (3)、 (2)、 (2)、 (2)和 (1)。如果男性是非西班牙裔白人、已婚、受过高等教育或来自高收入阶层,他们更有可能完成检测过程。

结论

在这里,我们展示了通过自愿、患者驱动、基于互联网的平台向 mPC 男性提供种系(遗传)基因检测的可行性。初步结果显示种系 DNA 修复突变率与其他队列一致。虽然对一些人可行,但需要减少参与步骤、更多专门的多样化外展和参与者支持,并确定和解决其他障碍,以确保公平获得和优化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f662/9928882/d87e9eb0b1f5/po-7-e2200104-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验